EU_flag_and_co-funded_by_health_programme.jpg

UNITO

UNIVERSITY OF TORIN (UNITO)
Department of oncology

The Department of Oncology at the Università di Torino (UNITO) is a pre-clinical and clinical research facility at San Luigi Hospital, Orbassano (Torino), Italy. The primary mission is to develop a continuum of research from basic sciences to clinical investigations, from epidemiology to health care. The Department has the administrative offices at San Luigi Hospital with seven full time employees. More than 75 faculty members in different areas of research, including public health, strive to attain significant improvement in patients affected by cancer. One of the Department’s aims is to stimulate collaborations between internal researchers and external groups and to produce, and disseminate to the general public, major scientific advances.

www.unito.it
www.sanluigi.piemonte.it

Several members of the Faculty, including all those directly involved in the current proposal, have experience in performing multicenter studies and have already been involved in the realization of national and international guidelines in different types of tumors, including mesothelioma. Library,  and information technology facilities are totally in place and sufficient for the project.
UNITO has a project management and research infrastructure and has also a dedicated Unit for contractual, legal and financial issues of European projects called Common Strategic Task Force (CSTF) located in Torino with sound administrative mechanisms in place for projects' management.

 

Key staff of the partner

Prof Giorgio V. Scagliotti, MD, PhD is Professor of Medical Oncology at the University of Torino, Director of the Medical Oncology Division at San Luigi Hospital and chairman of the Department of Oncology. He is one of the key experts in the field of thoracic tumors and he has been involved in experimental studies on basic and clinical applied research on thoracic cancers, including translational studies on mesothelioma. He has been and currently is the study coordinator of several European and international clinical trials on the treatment of advanced stage thoracic cancers and he has been a key investigator in several Italian studies on the role of chemotherapy in early stage non-small cell lung cancer. He has a long standing clinical experience in running institution initiated clinical studies. Prof. Scagliotti will be totally responsible for the coordination of the project (WP1) and will be supported by a full-time project manager (to be recruited).

Prof M. Papotti, MD, is professor of Pathology at the University of Torino and Head of Pathology Laboratory at San Luigi Hospital. His research interests include endocrine and thoracic pathology including the application of immunohistochemistry and molecular biology techniques to diagnostic histopathology, in order to identify new markers of neoplasia or characterize the phenotypic profile of several solid tumors and establish correlation with clinical and pathological parameters. He has direct experience in building and managing biological banks and he will be responsible at UNITO in directing all the activities of the consortium to facilitate all actions needed from  partners to collect information about the existing dedicated biological banks.

Dr Silvia Novello, MD, PhD, is respiratory physician on staff at the Thoracic Oncology Division at San Luigi Hospital. She has been and is the study coordinator (including the role of clinical supervisor) for clinical studies performed at her institution and with professional experience in clinical databases. She is trained both in respiratory medicine and medical oncology with previous fellowship in European oncology institutions. She is the president of an advocacy group dedicated to women with thoracic cancers (WALCE).

Dr. Luisella Righi, MD, is research pathologist at the Department of Oncology with a long standing interest in malignant mesothelioma.

Dr. Marco Cannizzo, MS, is the coordinator of the Medical Informatics Unit of the University of Torino.